Journal of Surgical Oncology

Cover image for Vol. 109 Issue 3

March 1, 2014

Volume 109, Issue 3

Pages 177–293

  1. Commentary

    1. Top of page
    2. Commentary
    3. Research Articles
    4. Editorial
    5. Research Articles
  2. Research Articles

    1. Top of page
    2. Commentary
    3. Research Articles
    4. Editorial
    5. Research Articles
    1. Does the mode of surgical resection affect the prognosis/recurrence in patients with thymoma? (pages 179–183)

      Kazuo Nakagawa, Hisao Asamura, Hiroyuki Sakurai, Shun-Ichi Watanabe and Koji Tsuta

      Version of Record online: 19 NOV 2013 | DOI: 10.1002/jso.23499

    2. Long-term outcome following surgical treatment of sacral chordoma (pages 184–188)

      Shunzo Osaka, Eiji Osaka, Toshio Kojima, Yukihiro Yoshida and Yasuaki Tokuhashi

      Version of Record online: 19 NOV 2013 | DOI: 10.1002/jso.23490

    3. TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer (pages 189–197)

      Kazuya Shinmura, Shinichiro Kiyose, Kiyoko Nagura, Hisaki Igarashi, Yusuke Inoue, Satoki Nakamura, Matsuyoshi Maeda, Megumi Baba, Hiroyuki Konno and Haruhiko Sugimura

      Version of Record online: 31 OCT 2013 | DOI: 10.1002/jso.23482

    4. Appropriate gastrectomy resection margins for early gastric carcinoma (pages 198–201)

      Beom Su Kim, Seong Tae Oh, Jeong Hwan Yook, Hee Sung Kim, In Seob Lee and Byung Sik Kim

      Version of Record online: 19 NOV 2013 | DOI: 10.1002/jso.23483

    5. You have full text access to this OnlineOpen article
      The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction (pages 202–207)

      Nathan J. Curtis, Fergus Noble, Ian S. Bailey, Jamie J. Kelly, James P. Byrne and Timothy J. Underwood

      Version of Record online: 14 NOV 2013 | DOI: 10.1002/jso.23484

    6. Efficacy of endoscopic gastroduodenal stenting for gastric outlet obstruction due to unresectable advanced gastric cancer: A prospective multicenter study (pages 208–212)

      Shunji Endo, Shuji Takiguchi, Yasuhiro Miyazaki, Kazuhiro Nishikawa, Hiroshi Imamura, Ko Takachi, Yutaka Kimura, Atsushi Takeno, Shigeyuki Tamura, Masaki Mori, Yuichiro Doki and on behalf of the CLINICAL STUDY GROUP OF OSAKA UNIVERSITY (CSGO), UPPER GI GROUP

      Version of Record online: 6 NOV 2013 | DOI: 10.1002/jso.23486

    7. Photodynamic diagnosis using 5-aminolevulinic acid during gastrectomy for gastric cancer (pages 213–217)

      Tsutomu Namikawa, Keiji Inoue, Sunao Uemura, Mai Shiga, Hiromichi Maeda, Hiroyuki Kitagawa, Hideo Fukuhara, Michiya Kobayashi, Taro Shuin and Kazuhiro Hanazaki

      Version of Record online: 8 NOV 2013 | DOI: 10.1002/jso.23487

    8. Ability of FDG-PET/CT in the detection of gallbladder cancer (pages 218–224)

      Carlos Ramos-Font, Manuel Gómez-Rio, Antonio Rodríguez-Fernández, Amelia Jiménez-Heffernan, Rocío Sánchez Sánchez and Jose Manuel Llamas-Elvira

      Version of Record online: 25 OCT 2013 | DOI: 10.1002/jso.23476

  3. Editorial

    1. Top of page
    2. Commentary
    3. Research Articles
    4. Editorial
    5. Research Articles
  4. Research Articles

    1. Top of page
    2. Commentary
    3. Research Articles
    4. Editorial
    5. Research Articles
    1. Lateral pelvic lymph node dissection can be omitted in lower rectal cancer in which the longest lateral pelvic and perirectal lymph node is less than 5 mm on MRI (pages 227–233)

      Shimpei Ogawa, Michio Itabashi, Tomoichiro Hirosawa, Takuzo Hashimoto, Yoshiko Bamba and Shingo Kameoka

      Version of Record online: 25 OCT 2013 | DOI: 10.1002/jso.23478

    2. Palliative surgery in patients with unresectable colorectal liver metastases: a propensity score matching analysis (pages 239–244)

      Yong Sik Yoon, Chan Wook Kim, Seok-Byung Lim, Chang Sik Yu, So Yeon Kim, Tae Won Kim, Min-Ju Kim and Jin Cheon Kim

      Version of Record online: 25 OCT 2013 | DOI: 10.1002/jso.23480

    3. Clinicopathological aspects of adenocarcinoma of the large bowel in a low incidence population (pages 245–249)

      Jonathan C.B. Dakubo, Simon S.B. Naaeder and Richard K. Gyasi

      Version of Record online: 19 NOV 2013 | DOI: 10.1002/jso.23489

    4. Pretreatment selection of regimen according to genetic analysis improves the efficacy of chemotherapy in the first line treatment of metastatic colorectal cancer (pages 250–254)

      Do Yoon Kim, Tae Yoon Paek, Seung Yeop Oh, Young Bae Kim, Je Hee Lee, Mi Young Lee, Zi Sun Choi and Kwang Wook Suh

      Version of Record online: 7 DEC 2013 | DOI: 10.1002/jso.23500

    5. Expression of apoptosis regulating proteins identifies stage II and III colon cancer patients with high risk of recurrence (pages 255–265)

      Eric J.Th. Belt, Hein B.A.C. Stockmann, Pien M. Delis-van Diemen, Herman Bril, Marianne Tijssen, Hendrik F. van Essen, Martijn W. Heymans, Jeroen A.M. Beliën, Beatriz Carvalho, Saskia A.G.M. Cillessen and Gerrit A. Meijer

      Version of Record online: 19 NOV 2013 | DOI: 10.1002/jso.23495

    6. Should a loop ileostomy closure in rectal cancer patients be done during or after adjuvant chemotherapy? (pages 266–269)

      Dr. Hagit Tulchinsky, Einat Shacham-Shmueli, Joseph M. Klausner, Moshe Inbar and Ravit Geva

      Version of Record online: 19 NOV 2013 | DOI: 10.1002/jso.23493

    7. Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: A series of 39 patients treated with palliative intent (pages 270–274)

      Nicola Solari, Francesco Spagnolo, Erica Ponte, Alberto Quaglia, Roberto Lillini, Michela Battista, Paola Queirolo and Ferdinando Cafiero

      Version of Record online: 28 OCT 2013 | DOI: 10.1002/jso.23481

    8. Examination of the cutoff value of postchemotherapy increase in tumor volume as a predictor of subsequent oncologic events in stage IIB osteosarcoma (pages 275–279)

      Dae-Geun Jeon, Chang-Bae Kong, Wan Hyeong Cho, Won Seok Song, Sang Hyun Cho, Sung Woo Choi and Soo-Yong Lee

      Version of Record online: 14 NOV 2013 | DOI: 10.1002/jso.23496

    9. Multimodal treatment of locally advanced esophageal adenocarcinoma: Which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients (pages 287–293)

      Jens Hoeppner, Katja Zirlik, Thomas Brunner, Peter Bronsert, Birte Kulemann, Olivia Sick, Goran Marjanovic, Ulrich Theodor Hopt and Frank Makowiec

      Version of Record online: 26 NOV 2013 | DOI: 10.1002/jso.23498

SEARCH

SEARCH BY CITATION